Raymond James Financial’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.07M Buy
473,311
+353,704
+296% +$2.73M ﹤0.01% 2717
2026
Q1
$762K Sell
119,607
-149,190
-56% -$1.04M ﹤0.01% 4060
2025
Q4
$1.89M Sell
268,797
-1,423
-0.5% -$8.59K ﹤0.01% 3316
2025
Q3
$1.49M Sell
270,220
-19,320
-7% -$94.7K ﹤0.01% 3406
2025
Q2
$1.5M Buy
289,540
+414
+0.1% +$2.48K ﹤0.01% 3299
2025
Q1
$1.93M Buy
+289,126
New +$2.2M ﹤0.01% 3012

Other funds holding LFST

Raymond James Financial's LFST Position: Q2 2026 in Review

Raymond James Financial increased its Lifestance Health (LFST) stake by 296% in Q2 2026, buying an estimated $2.73M and bringing the position to 473,311 shares worth $5.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2717.

Raymond James Financial first reported a position in LFST in Q1 2025 and has held it in 6 quarters since. 288 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Raymond James Financial held 473,311 shares of Lifestance Health worth $5.07M as of Q2 2026.
  • Raymond James Financial bought 353,704 Lifestance Health shares in Q2 2026, an estimated $2.73M.
  • Lifestance Health made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #2717 holding.
  • Raymond James Financial first reported a position in Lifestance Health in Q1 2025 and has held it in 6 quarters since.
  • 288 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.